Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Contraception and Contraceptive Drugs

  Free Subscription

Articles published in Gynecol Endocrinol

Retrieve available abstracts of 49 articles:
HTML format

Single Articles

    June 2022
  1. OKYAY RE, Cetintas B, Akdoner A, Oztura I, et al
    The effect of oral contraceptive use on sympatic nerve activity in patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2022 Jun 7:1-6. doi: 10.1080/09513590.2022.2082403.
    PubMed     Abstract available

    May 2022
  2. LEPPANEN R, Tinkanen H, Huhtala H, Ahinko K, et al
    Single-administered GnRH agonist as luteal phase support in insemination cycles: a randomized controlled trial.
    Gynecol Endocrinol. 2022;38:438-442.
    PubMed     Abstract available

    April 2022
  3. REGIDOR PA, Palacios S, Colli E
    Bleeding profile of women with cardiovascular risk factors using a drospirenone only pill with 4 mg over nine cycles compared to desogestrel 0.075 mg.
    Gynecol Endocrinol. 2022;38:333-338.
    PubMed     Abstract available

    March 2022
  4. KIZILKAYA Y, Ibanoglu MC, Kiykac Altinbas S, Engin-Ustun Y, et al
    A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms.
    Gynecol Endocrinol. 2022 Mar 23:1-4. doi: 10.1080/09513590.2022.2053956.
    PubMed     Abstract available

  5. VANNUCCINI S, Biagiotti C, Esposto MC, La Torre F, et al
    Long-term treatment of endometriosis-related pain among women seeking hormonal contraception.
    Gynecol Endocrinol. 2022 Mar 3:1-5. doi: 10.1080/09513590.2022.2047172.
    PubMed     Abstract available

    January 2022
  6. TRIGO ACM, Maron CC, Pinheiro MSA, da Silva SBL, et al
    Female sexual function in women using LARC methods.
    Gynecol Endocrinol. 2022;38:68-72.
    PubMed     Abstract available

    December 2021
  7. BUGGIO L, Barbara G, Facchin F, Ghezzi L, et al
    The influence of hormonal contraception on depression and female sexuality: a narrative review of the literature.
    Gynecol Endocrinol. 2021 Dec 16:1-9. doi: 10.1080/09513590.2021.2016693.
    PubMed     Abstract available

    November 2021
  8. JI M, Yuan M, Jiao X, Li Q, et al
    A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
    Gynecol Endocrinol. 2021 Nov 9:1-6. doi: 10.1080/09513590.2021.2000961.
    PubMed     Abstract available

    September 2021
  9. FERREIRA-FILHO ES, Bahamondes L, Duarte DC, Guimaraes ALM, et al
    Etonogestrel-releasing contraceptive implant in a patient using thalidomide for the treatment of erythema nodosum leprosum: a case report.
    Gynecol Endocrinol. 2021 Sep 6:1-4. doi: 10.1080/09513590.2021.1974380.
    PubMed     Abstract available

    August 2021
  10. REGIDOR PA, Colli E, Palacios S
    Overall and bleeding-related discontinuation rates of a new oral contraceptive containing 4 mg drospirenone only in a 24/4 regimen and comparison to 0.075 mg desogestrel.
    Gynecol Endocrinol. 2021 Aug 17:1-7. doi: 10.1080/09513590.2021.1963432.
    PubMed     Abstract available

  11. NIE L, Zou H, Ma X, Cheng L, et al
    A clinical observational study on the efficacy of subcutaneous etonogestrel implants for adenomyosis in 20 patients.
    Gynecol Endocrinol. 2021;37:735-739.
    PubMed     Abstract available

    June 2021
  12. YAO W, Dong X, Yu X, Luo J, et al
    The use of oral contraceptive is inversely associated with the risk of type 2 diabetes mellitus among middle-aged women.
    Gynecol Endocrinol. 2021 Jun 1:1-6. doi: 10.1080/09513590.2021.1932802.
    PubMed     Abstract available

    May 2021
  13. NICOLAS I, Martinez-Zamora MA, Gracia M, Carrion A, et al
    Management of symptomatic uterine fibroids after ulipristal acetate suspension and identification of high risk patients for surgery at 6-months of follow-up.
    Gynecol Endocrinol. 2021 May 28:1-5. doi: 10.1080/09513590.2021.1929152.
    PubMed     Abstract available

  14. CECCARONI M, Clarizia R, Liverani S, Donati A, et al
    Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
    Gynecol Endocrinol. 2021 May 26:1-4. doi: 10.1080/09513590.2021.1929151.
    PubMed     Abstract available

  15. LI J, Sun Y, Mo S, Wang S, et al
    Effects of oral contraceptive for different responder women before GnRH antagonists: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2021 May 11:1-10. doi: 10.1080/09513590.2021.1918664.
    PubMed     Abstract available

    March 2021
  16. MARIANI LL, Novara L, Mancarella M, Fuso L, et al
    Estradiol/nomegestrol acetate as a first-line and rescue therapy for the treatment of ovarian and deep infiltrating endometriosis.
    Gynecol Endocrinol. 2021 Mar 22:1-4. doi: 10.1080/09513590.2021.1903420.
    PubMed     Abstract available

  17. PIACENTI I, Viscardi MF, Masciullo L, Sangiuliano C, et al
    Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what's the best choice?
    Gynecol Endocrinol. 2021 Mar 2:1-5. doi: 10.1080/09513590.2021.1892632.
    PubMed     Abstract available

  18. TROIA L, Martone S, Morgante G, Luisi S, et al
    Management of perimenopause disorders: hormonal treatment.
    Gynecol Endocrinol. 2021;37:195-200.
    PubMed     Abstract available

    February 2021
  19. BUYUK GN, Oskovi-Kaplan ZA, Kansu-Celik H, Neselioglu S, et al
    Copper and levonorgestrel containing intrauterine devices: comparison of their effect on oxidative stress markers.
    Gynecol Endocrinol. 2021 Feb 17:1-4. doi: 10.1080/09513590.2021.1878132.
    PubMed     Abstract available

  20. CLEMENZA S, Vannuccini S, Capezzuoli T, Meleca CI, et al
    Is primary dysmenorrhea a precursor of future endometriosis development?
    Gynecol Endocrinol. 2021 Feb 11:1-7. doi: 10.1080/09513590.2021.1878134.
    PubMed     Abstract available

    January 2021
  21. ATAKUL T, Tayyar AT, Turan OD, Celik SY, et al
    An assessment of the protective effect of gonadotropin-releasing hormone agonist and antagonist on bleomycin-induced ovarian toxicity in rats.
    Gynecol Endocrinol. 2021;37:46-50.
    PubMed     Abstract available

    October 2020
  22. LI X, Zhang X, Cai J, Pang J, et al
    Granulosa cells apoptosis and follicular fluid hormones: comparison of progestin-primed ovarian stimulation versus GnRH antagonist protocols.
    Gynecol Endocrinol. 2020 Oct 23:1-5. doi: 10.1080/09513590.2020.1822802.
    PubMed     Abstract available

    September 2020
  23. ZHAO Y, Luan X, Wang Y
    Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study.
    Gynecol Endocrinol. 2020 Sep 16:1-5. doi: 10.1080/09513590.2020.1807502.
    PubMed     Abstract available

    August 2020
  24. MASSAROTTI C, Lo Monaco L, Scaruffi P, Sozzi F, et al
    Contraception in cancer survivors: insights from oncofertility follow-up visits.
    Gynecol Endocrinol. 2020 Aug 25:1-5. doi: 10.1080/09513590.2020.1810658.
    PubMed     Abstract available

  25. NAPPI RE, Tiranini L
    "50 Shades of sex" under hormonal contraception.
    Gynecol Endocrinol. 2020 Aug 21:1-2. doi: 10.1080/09513590.2020.1811847.

    June 2020
  26. BATTAGLIA C, Battaglia B, Casadio P, Rizzo R, et al
    Metformin metabolic and vascular effects in normal weight hyperinsulinemic polycystic ovary syndrome patients treated with contraceptive vaginal ring. A pilot study.
    Gynecol Endocrinol. 2020 Jun 16:1-8. doi: 10.1080/09513590.2020.1770213.
    PubMed     Abstract available

  27. STEFANIAK A, Domitrz J, Siewko K, Szelachowska M, et al
    Pituitary adenoma and apoplexy during GnRH agonist treatment for IVF - case report.
    Gynecol Endocrinol. 2020;36:561-563.
    PubMed     Abstract available

    May 2020
  28. LANDERSOE SK, Larsen EC, Forman JL, Birch Petersen K, et al
    Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH?
    Gynecol Endocrinol. 2020 May 2:1-6. doi: 10.1080/09513590.2020.1756250.
    PubMed     Abstract available

  29. DEL FORNO S, Degli Esposti E, Salucci P, Leonardi D, et al
    Liver function, tolerability and satisfaction during treatment with ulipristal acetate in women with fibroids: a single center experience.
    Gynecol Endocrinol. 2020;36:445-447.
    PubMed     Abstract available

    April 2020
  30. LASORELLA S, Porto R, Iezzi ML, Pistone C, et al
    Comparison of triptorelin acetate vs triptorelin pamoate in the treatment of Central precocious puberty (CPP): a retrospective study.
    Gynecol Endocrinol. 2020;36:338-340.
    PubMed     Abstract available

    February 2020
  31. BARRIGA POOLEY P, Von Hoveling A, Galan G, Lopez Berroa J, et al
    Analysis and new contraception frontiers with combined vaginal rings.
    Gynecol Endocrinol. 2020 Feb 24:1-4. doi: 10.1080/09513590.2020.1729730.
    PubMed     Abstract available

  32. HADJI P, Neulen J, Schaudig K, Schwenkhagen A, et al
    Extended-cycle versus conventional treatment with a combined oral contraceptive containing ethinylestradiol (30 mug) and levonorgestrel (150 mug) in a randomized controlled trial.
    Gynecol Endocrinol. 2020 Feb 16:1-8. doi: 10.1080/09513590.2020.1725963.
    PubMed     Abstract available

  33. VIGNALI M, Belloni GM, Pietropaolo G, Barbasetti Di Prun A, et al
    Effect of Dienogest therapy on the size of the endometrioma.
    Gynecol Endocrinol. 2020 Feb 16:1-5. doi: 10.1080/09513590.2020.1725965.
    PubMed     Abstract available

    December 2019
  34. PALAIA I, Del Negro V, Fracassi A, Schiavi M, et al
    Efficacy of ulipristal acetate (UPA) for the treatment of expulsion uterine myomas: report of two cases.
    Gynecol Endocrinol. 2019 Dec 26:1-2. doi: 10.1080/09513590.2019.1707795.
    PubMed     Abstract available

  35. XHOLLI A, Filip G, Previtera F, Cagnacci A, et al
    Modification of endometrioma size during hormone therapy containing dienogest.
    Gynecol Endocrinol. 2019 Dec 16:1-5. doi: 10.1080/09513590.2019.1703942.
    PubMed     Abstract available

    November 2019
  36. FERRERO S, Scala C, Ciccarelli S, Vellone VG, et al
    Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant.
    Gynecol Endocrinol. 2019 Nov 12:1-5. doi: 10.1080/09513590.2019.1689552.
    PubMed     Abstract available

    October 2019
  37. MATSUSHIMA T, Akira S, Yoneyama K, Takeshita T, et al
    Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
    Gynecol Endocrinol. 2019 Oct 29:1-4. doi: 10.1080/09513590.2019.1683818.
    PubMed     Abstract available

    August 2019
  38. PALAIA I, Bardhi E, Boccia SM, Pecorini F, et al
    Severe hemoperitoneum due to endometriosis in a non-pregnant woman under dienogest therapy: a case report.
    Gynecol Endocrinol. 2019 Aug 13:1-2. doi: 10.1080/09513590.2019.1653843.
    PubMed     Abstract available

  39. GIARRE G, Franchini M, Castellacci E, Malune ME, et al
    Ulipristal acetate in symptomatic uterine fibroids. A real-world experience in a multicentric Italian study.
    Gynecol Endocrinol. 2019 Aug 8:1-4. doi: 10.1080/09513590.2019.1648419.
    PubMed     Abstract available

    July 2019
  40. BISCIONE A, Barra V, Bellone E, Severi FM, et al
    Ulipristal acetate on quality of life and sexual function of women with uterine fibromatosis.
    Gynecol Endocrinol. 2019 Jul 22:1-6. doi: 10.1080/09513590.2019.1640202.
    PubMed     Abstract available

  41. RIZZELLO F, Ralli E, Romanelli C, Coccia ME, et al
    Severe recurrent endometriomas in a young woman with congenital von Willebrand disease.
    Gynecol Endocrinol. 2019 Jul 16:1-3. doi: 10.1080/09513590.2019.1641481.
    PubMed     Abstract available

  42. ANGIONI S, Pontis A, Malune ME, Cela V, et al
    Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study.
    Gynecol Endocrinol. 2019 Jul 16:1-3. doi: 10.1080/09513590.2019.1640674.
    PubMed     Abstract available

  43. MUZII L, Galati G, Di Tucci C, Di Feliciantonio M, et al
    Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain.
    Gynecol Endocrinol. 2019 Jul 14:1-3. doi: 10.1080/09513590.2019.1640199.
    PubMed     Abstract available

  44. YE H, Luo X, Pei L, Li F, et al
    The addition of single dose GnRH agonist to luteal phase support in artificial cycle frozen embryo transfer: a randomized clinical trial.
    Gynecol Endocrinol. 2019;35:618-622.
    PubMed     Abstract available

    May 2019
  45. MARTINEZ F, Rodriguez-Purata J, Clua E, Garcia S, et al
    Ovarian response in oocyte donation cycles under LH suppression with GnRH antagonist or desogestrel progestin: retrospective and comparative study.
    Gynecol Endocrinol. 2019 May 12:1-6. doi: 10.1080/09513590.2019.1604662.
    PubMed     Abstract available

  46. MARTINEZ F, Rodriguez-Purata J, Beatriz Rodriguez D, Clua E, et al
    Desogestrel versus antagonist injections for LH suppression in oocyte donation cycles: a crossover study.
    Gynecol Endocrinol. 2019 May 7:1-6. doi: 10.1080/09513590.2019.1604661.
    PubMed     Abstract available

    March 2019
  47. NERI M, Pilloni M, Paoletti AM, Melis GB, et al
    Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health.
    Gynecol Endocrinol. 2019 Mar 1:1-6. doi: 10.1080/09513590.2019.1576618.
    PubMed     Abstract available

    January 2019
  48. CIEBIERA M, Meczekalski B, Lukaszuk K, Jakiel G, et al
    Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy - 2 case studies.
    Gynecol Endocrinol. 2019 Jan 11:1-5. doi: 10.1080/09513590.2018.1550062.
    PubMed     Abstract available

    May 2018
  49. JEONG SH, Lee D, Kim SK, Jee BC, et al
    Symptom-alleviating effect and adverse effect of dienogest in Korean women with endometriosis.
    Gynecol Endocrinol. 2018 May 7:1-5. doi: 10.1080/09513590.2018.1469610.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.